Investigation of the Effectiveness of a Home Exercise Program

Investigation of the Effectiveness of a Home Exercise Program in Individuals With Temporomandibular Joint Disc Displacement With Reduction

The purpose of this study is to examine the effects of a home exercise program on individuals with temporomandibular joint disc displacement with reduction. Participants will be assessed at baseline and again after a four-week home exercise program.

Study Overview

• Status: Completed
• Conditions: Temporomandibular Joint Disc Displacement
• Intervention / Treatment: Other: Home exercise; Other: Patient education

Detailed Description

Participants who meet the inclusion criteria will be randomly divided into 2 groups. The first group, called the study group, will receive a home exercise program and patient education. The second group, called the control group, will receive only patient education. Participants will be assessed at baseline and again after a four-week home exercise program.

• Study Type: Observational
• Enrollment (Actual): 40

Contacts and Locations

Study Locations

• Turkey
  • Trabzon, Turkey, 61000
    • Karadeniz Technical University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients with Temporomandibular joint disc displacement with reduction

Description

Inclusion Criteria:

• 18 and 65 years,
• who have had complaints related to TMJ for at least 3 months,
• who have been diagnosed with Temporomandibular joint disc displacement with reduction as a result of clinical and radiological evaluation by a dentist

Exclusion Criteria:

• Those with cognitive problems,
• any systemic joint or muscle disease (e.g. fibromyalgia, rheumatoid arthritis),
• serious systemic diseases,
• any neurological disorder (e.g. trigeminal neuralgia),
• pregnancy, breastfeeding,
• who have previously been treated for TMJ or orofacial muscle pain

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Group 1 study group; Home exercise group and patient education	Other: Home exercise; The study group will be given exercises that include temporomandibular joint and neck as a home exercise program.; Other: Patient education; Information about the disease and symptoms, chewing recommendations, dietary changes, parafunctional habits, activities to avoid, posture training
Group 2 control group; Only patient education	Other: Patient education; Information about the disease and symptoms, chewing recommendations, dietary changes, parafunctional habits, activities to avoid, posture training

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Range of motion	Range of motion of temporomandibular joint	an average one month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Numeric Pain scale	Pain severity assessment	an average one month
Mandibular Function Impairment Questionnaire	Assessment of mandibular function	an average one month

Collaborators and Investigators

• Sponsor: Karadeniz Technical University
• Investigators: Principal Investigator: Nurhayat korkmaz, Msc, Karadeniz Technical University

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2023
• Primary Completion (Actual): April 28, 2025
• Study Completion (Actual): May 30, 2025

Study Registration Dates

• First Submitted: January 27, 2025
• First Submitted That Met QC Criteria: January 27, 2025
• First Posted (Actual): January 31, 2025

Study Record Updates

• Last Update Posted (Actual): July 17, 2025
• Last Update Submitted That Met QC Criteria: July 15, 2025
• Last Verified: July 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: KTU-FTR-2024/7

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No